Nigella Sativa a Promising Drug in Treatment of Diabetes and Prevention of Its Complication
DOI:
https://doi.org/10.7439/ijbar.v10i12.5292Keywords:
Nigella sativa, Glycosylated hemoglobin, HbA1c, Type 1 diabetic patients, hypoglycemic effectAbstract
Introduction: Nigella sativa (NS) - an annual herb belongs to the family Ranunculaceae
Downloads
Download data is not yet available.
Downloads
Published
2019-12-31
Issue
Section
Original Research Articles
License
Copyright (c) 2019 International Journal of Biomedical and Advance Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
Nigella Sativa a Promising Drug in Treatment of Diabetes and Prevention of Its Complication. (2019). International Journal of Biomedical and Advance Research, 10(12), e5292. https://doi.org/10.7439/ijbar.v10i12.5292
